Biemans; Ralph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Biemans; Ralph.The latest application filed is for "neisserial vaccine compositions comprising a combination of antigens".

Company Profile

0.6.16

Biemans; Ralph - Rixensart BE
Biemans; Ralph - King of Prussia PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Neisserial Vaccine Compositions Comprising A Combination Of Antigens App 20160082097 - Berthet; Francois-Xavier Jacques ; et al.	2016-03-24
Method of detoxification Grant 8,815,254 - Biemans , et al. August 26, 2	2014-08-26
Method Of Detoxification App 20140010843 - BIEMANS; Ralph ; et al.	2014-01-09
Method of producing an immunogenic composition Grant 8,309,327 - Biemans , et al. November 13, 2	2012-11-13
Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis Grant 8,221,770 - Biemans , et al. July 17, 2	2012-07-17
Neisserial Vaccine Compositions Comprising A Combination Of Antigens App 20120064119 - Berthet; Francois-Xavier Jacques ; et al.	2012-03-15
Neisserial Vaccine Compositions Comprising A Combination Of Antigens App 20120064120 - Berthet; Francois-Xavier Jacques ; et al.	2012-03-15
Neisserial Vaccine Compositions Comprising A Combination Of Antigens App 20120027800 - Berthet; Francois-Xavier Jacques ; et al.	2012-02-02
Purification process for bacterial cytolysin Grant 8,084,235 - Biemans , et al. December 27, 2	2011-12-27
Method Of Producing A Vaccine App 20110311577 - Biemans; Ralph ; et al.	2011-12-22
Vaccine Compositions Comprising L2 And/or L3 Immunotype Lipooligosaccharides From Lgtb-neisseria Meningitidis App 20110033500 - Biemans; Ralph ; et al.	2011-02-10
Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB- Neisseria meningitidis Grant 7,838,014 - Biemans , et al. November 23, 2	2010-11-23
Method For Refolding Neisserial Nspa Protein App 20100291137 - Biemans; Ralph ; et al.	2010-11-18
Method for Refolding Neisserial Nspa Protein App 20080025993 - Biemans; Ralph ; et al.	2008-01-31
Purification process for bacterial cytolysin App 20070026010 - Biemans; Ralph ; et al.	2007-02-01
Neisserial vaccine compositions comprising a combination of antigens App 20060240045 - Berthet; Francois-Xavier ; et al.	2006-10-26
Mutant protein and refolding method App 20060141563 - Biemans; Ralph ; et al.	2006-06-29
Vaccine composition App 20060057160 - Biemans; Ralph ; et al.	2006-03-16
Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis App 20060051379 - Biemans; Ralph ; et al.	2006-03-09
Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria App 20060034854 - Berthet; Francois-Xavier Jacques ; et al.	2006-02-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.